The proportion of endometrial cancers associated with Lynch syndrome: a systematic review of the literature and meta-analysis

[1]  P. Møller,et al.  The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome , 2019, Genetics in Medicine.

[2]  D. Evans,et al.  The prevalence of Lynch syndrome in women with endometrial cancer: a systematic review protocol , 2018, Systematic Reviews.

[3]  M. Kloor,et al.  Three molecular pathways model colorectal carcinogenesis in Lynch syndrome , 2018, International journal of cancer.

[4]  L. Tafe,et al.  Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome. , 2017, Human pathology.

[5]  D. Evans,et al.  Association of Mismatch Repair Mutation With Age at Cancer Onset in Lynch Syndrome , 2017, JAMA oncology.

[6]  S. Fox,et al.  Lessons learnt from implementation of a Lynch syndrome screening program for patients with gynaecological malignancy. , 2017, Pathology.

[7]  P. Scollo,et al.  Genetic screening in young women diagnosed with endometrial cancer , 2016, Journal of gynecologic oncology.

[8]  R. Berkowitz,et al.  Universal Screening for Mismatch-Repair Deficiency in Endometrial Cancers to Identify Patients With Lynch Syndrome and Lynch-like Syndrome , 2016, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[9]  M. Dwyer,et al.  Genetic/Familial High-Risk Assessment: Colorectal Version 1.2016, NCCN Clinical Practice Guidelines in Oncology. , 2016, Journal of the National Comprehensive Cancer Network : JNCCN.

[10]  R. Broaddus,et al.  Germline multi-gene hereditary cancer panel testing in an unselected endometrial cancer cohort , 2016, Modern Pathology.

[11]  M. Tejada,et al.  Analysis of Lynch Syndrome Mismatch Repair Genes in Women with Endometrial Cancer , 2016, Oncology.

[12]  R. Tekmal,et al.  Clinical and Pathologic Features of Hispanic Endometrial Cancer Patients With Loss of Mismatch Repair Expression. , 2016, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

[13]  C. Vaccaro,et al.  Endometrial cancer and Lynch syndrome: Immunohistochemical characterization of endometrial cancer associated with changes in mismatch repair protein expression , 2016 .

[14]  D. Lin,et al.  Targeted Screening With Combined Age- and Morphology-Based Criteria Enriches Detection of Lynch Syndrome in Endometrial Cancer , 2016, International journal of surgical pathology.

[15]  E. Darai,et al.  Endometrial cancer , 2016, The Lancet.

[16]  H. Hampel.  Genetic counseling and cascade genetic testing in Lynch syndrome , 2016, Familial Cancer.

[17]  Y. Terada,et al.  Isolated Loss of PMS2 Immunohistochemical Expression is Frequently Caused by Heterogenous MLH1 Promoter Hypermethylation in Lynch Syndrome Screening for Endometrial Cancer Patients , 2016, The American journal of surgical pathology.

[18]  Molecular testing strategies for Lynch syndrome in people with colorectal cancer , 2022 .

[19]  P. Møller,et al.  Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database , 2015, Gut.

[20]  A. Stuckey,et al.  Evaluation of universal immunohistochemistry screening for diagnosing Lynch syndrome in endometrial cancer patients at a tertiary care center , 2015 .

[21]  L. Buchynska,et al.  The study of mismatch repair in endometrial cancer patients with a family history of cancer. , 2015, Experimental oncology.

[22]  F. Gao,et al.  Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  R. Pai,et al.  Clinicopathological comparison of colorectal and endometrial carcinomas in patients with Lynch-like syndrome versus patients with Lynch syndrome. , 2015, Human pathology.

[24]  Gail M. Williams,et al.  Advances in the meta-analysis of heterogeneous clinical trials I: The inverse variance heterogeneity model. , 2015, Contemporary clinical trials.

[25]  P. Laird,et al.  Clinicopathologic Risk Factor Distributions for MLH1 Promoter Region Methylation in CIMP-Positive Tumors , 2015, Cancer Epidemiology, Biomarkers & Prevention.

[26]  H. Ngan,et al.  The Significance of Mismatch Repair Deficiency in Young Patients With Endometrial Cancer , 2015, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[27]  Alan Barkun,et al.  American Gastroenterological Association Institute Guideline on the Diagnosis and Management of Lynch Syndrome. , 2015, Gastroenterology.

[28]  D. Bishop,et al.  Obesity, Aspirin, and Risk of Colorectal Cancer in Carriers of Hereditary Colorectal Cancer: A Prospective Investigation in the CAPP2 Study. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  A. Talhouk,et al.  Detection of DNA mismatch repair (MMR) deficiencies by immunohistochemistry can effectively diagnose the microsatellite instability (MSI) phenotype in endometrial carcinomas. , 2015, Gynecologic oncology.

[30]  F. Gao,et al.  Impact of an immunohistochemistry-based universal screening protocol for Lynch syndrome in endometrial cancer on genetic counseling and testing. , 2015, Gynecologic oncology.

[31]  Christopher D. Heinen,et al.  Milestones of Lynch syndrome: 1895–2015 , 2015, Nature Reviews Cancer.

[32]  D. Evans,et al.  Improving the uptake of predictive testing and colorectal screening in Lynch syndrome: a regional primary care survey , 2015, Clinical genetics.

[33]  Y. Terada,et al.  Efficient screening strategy for Lynch syndrome in Japanese endometrial cancer. , 2015, The Tohoku journal of experimental medicine.

[34]  H. Mackay,et al.  Performance characteristics of screening strategies for Lynch syndrome in unselected women with newly diagnosed endometrial cancer who have undergone universal germline mutation testing , 2014, Cancer.

[35]  R. Pai,et al.  Lynch Syndrome Screening Should Be Considered for All Patients With Newly Diagnosed Endometrial Cancer , 2014, The American journal of surgical pathology.

[36]  P. Cheah,et al.  The Immunohistochemistry Signature of Mismatch Repair (MMR) Proteins in a Multiethnic Asian Cohort With Endometrial Carcinoma , 2014, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[37]  Q. Long,et al.  Role of endometrial cancer abnormal MMR protein in screening Lynch-syndrome families. , 2014, International journal of clinical and experimental pathology.

[38]  R. Broaddus,et al.  Consequences of universal MSI/IHC in screening ENDOMETRIAL cancer patients for Lynch syndrome. , 2014, Gynecologic oncology.

[39]  A. Karnezis,et al.  Association of Tumor Morphology With Mismatch-repair Protein Status in Older Endometrial Cancer Patients: Implications for Universal Versus Selective Screening Strategies for Lynch Syndrome , 2014, The American journal of surgical pathology.

[40]  R. Broaddus,et al.  Evaluation of Clinical Criteria for the Identification of Lynch Syndrome among Unselected Patients with Endometrial Cancer , 2014, Cancer Prevention Research.

[41]  P. Goodfellow,et al.  Mismatch repair protein expression in 1049 endometrial carcinomas, associations with body mass index, and other clinicopathologic variables. , 2014, Gynecologic oncology.

[42]  Alexander M. Metcalf,et al.  Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  F. Aranda,et al.  Prevalence of Lynch Syndrome among Patients with Newly Diagnosed Endometrial Cancers , 2013, PloS one.

[44]  Harold E. Nelson,et al.  Endometrial cancer and a family history of cancer. , 2013, Gynecologic oncology.

[45]  D. Evans,et al.  Reduced life expectancy seen in hereditary diseases which predispose to early-onset tumors , 2013, The application of clinical genetics.

[46]  C. Eng,et al.  Implementation of tumor testing for lynch syndrome in endometrial cancers at a large academic medical center. , 2013, Gynecologic oncology.

[47]  A. Spurdle,et al.  Improving identification of lynch syndrome patients: A comparison of research data with clinical records , 2013, International journal of cancer.

[48]  K. Atkins,et al.  Women 50 Years Or Younger With Endometrial Cancer: The Argument for Universal Mismatch Repair Screening and Potential for Targeted Therapeutics , 2013, International Journal of Gynecologic Cancer.

[49]  F. Escande,et al.  Evaluation of a new panel of six mononucleotide repeat markers for the detection of DNA mismatch repair-deficient tumours , 2013, British Journal of Cancer.

[50]  R. Broaddus,et al.  Relationship between PTEN, DNA Mismatch Repair, and Tumor Histotype in Endometrial Carcinoma: Retained Positive Expression of PTEN Preferentially Identifies Sporadic Non-Endometrioid Carcinomas , 2013, Modern Pathology.

[51]  P. Møller,et al.  Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts , 2013, Gut.

[52]  Rochelle L. Garcia,et al.  BRCA1, TP53, and CHEK2 germline mutations in uterine serous carcinoma , 2013, Cancer.

[53]  J. Potter,et al.  Identification of Lynch syndrome among patients with colorectal cancer. , 2012, JAMA.

[54]  E. Kuipers,et al.  Prospective evaluation of molecular screening for Lynch syndrome in patients with endometrial cancer ≤ 70 years. , 2012, Gynecologic oncology.

[55]  A. P. Ortiz,et al.  Case-Case Study of Factors Associated to hMLH1, hMSH2, and hMSH6 Protein Expression Among Endometrial Cancer Patients of the University District Hospital of San Juan, Puerto Rico , 2012, International Journal of Gynecologic Cancer.

[56]  L. Ragolia,et al.  Retrospective review of endometrial cancer (EC) specimens in individuals younger than age 50 for microsatellite instability (MSI) testing and DNA mismatch repair enzyme (MMR) expression. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[57]  D. Bishop,et al.  Microsatellite Instability and DNA Methylation of Endometrial Tumors and Clinical Features in Young Women Compared With Older Women , 2010, International Journal of Gynecologic Cancer.

[58]  F. Fostira,et al.  Screening of the DNA mismatch repair genes MLH1, MSH2 and MSH6 in a Greek cohort of Lynch syndrome suspected families , 2010, BMC Cancer.

[59]  J. Prolla,et al.  Clinical and histomolecular endometrial tumor characterization of patients at-risk for Lynch syndrome in South of Brazil , 2010, Familial Cancer.

[60]  W. Frankel,et al.  Prospective evaluation of DNA mismatch repair protein expression in primary endometrial cancer. , 2009, Gynecologic oncology.

[61]  K. Garg,et al.  Lynch syndrome (hereditary non-polyposis colorectal cancer) and endometrial carcinoma , 2009, Journal of Clinical Pathology.

[62]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement , 2009, BMJ : British Medical Journal.

[63]  R. Fishel,et al.  Current and emerging trends in Lynch syndrome identification in women with endometrial cancer. , 2009, Gynecologic oncology.

[64]  Fan Wang,et al.  Meta-Analysis of MSH6 Gene Mutation Frequency in Colorectal and Endometrial Cancers , 2009, Journal of toxicology and environmental health. Part A.

[65]  D. Evans,et al.  Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations , 2009, Clinical genetics.

[66]  R. Broaddus,et al.  Endometrial cancer and Lynch syndrome: clinical and pathologic considerations. , 2009, Cancer control : journal of the Moffitt Cancer Center.

[67]  U. Manne,et al.  Lynch Syndrome in Women Less Than 50 Years of Age With Endometrial Cancer , 2008, Obstetrics and gynecology.

[68]  A. Spurdle,et al.  Molecular, Pathologic, and Clinical Features of Early-Onset Endometrial Cancer: Identifying Presumptive Lynch Syndrome Patients , 2008, Clinical Cancer Research.

[69]  N. Park,et al.  Hereditary nonpolyposis colorectal cancer in endometrial cancer patients , 2007, International journal of cancer.

[70]  R. Broaddus,et al.  Prospective determination of prevalence of lynch syndrome in young women with endometrial cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[71]  W. Frankel,et al.  Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. , 2006, Cancer research.

[72]  A. Duval,et al.  Detection of microsatellite instability in endometrial cancer: advantages of a panel of five mononucleotide repeats over the National Cancer Institute panel of markers. , 2006, Carcinogenesis.

[73]  S. Duffy,et al.  The detection of microsatellite instability in blind endometrial samples—a potential novel screening tool for endometrial cancer in women from hereditary nonpolyposis colorectal cancer families? , 2005, International Journal of Gynecologic Cancer.

[74]  W. Frankel,et al.  Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). , 2005, The New England journal of medicine.

[75]  R. Broaddus,et al.  Gynecologic Cancer as a “Sentinel Cancer” for Women With Hereditary Nonpolyposis Colorectal Cancer Syndrome , 2005, Obstetrics and gynecology.

[76]  Patrick Neven,et al.  Endometrial cancer. , 2005, Lancet.

[77]  P. Goodfellow,et al.  Increased Risk for Hereditary Nonpolyposis Colorectal Cancer-Associated Synchronous and Metachronous Malignancies in Patients with Microsatellite Instability-Positive Endometrial Carcinoma Lacking MLH1 Promoter Methylation , 2004, Clinical Cancer Research.

[78]  H. Hollema,et al.  Toward new strategies to select young endometrial cancer patients for mismatch repair gene mutation analysis. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[79]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[80]  R. Chadwick,et al.  Hereditary and somatic DNA mismatch repair gene mutations in sporadic endometrial carcinoma , 2001, Journal of Medical Genetics.

[81]  J. Coyne,et al.  Factors associated with decisions about clinical BRCA1/2 testing. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[82]  D. Schaid,et al.  Microsatellite instability and hMLH1/hMSH2 expression in young endometrial carcinoma patients: Associations with family history and histopathology , 2000, International journal of cancer.

[83]  X. Matías-Guiu,et al.  Microsatellite instability in endometrial carcinomas: clinicopathologic correlations in a series of 42 cases. , 1998, Human pathology.

[84]  S. Thibodeau,et al.  Absence of mutations in DNA mismatch repair genes in sporadic endometrial tumors with microsatellite instability. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.